| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Fundraising > Nonprofit Fundraising - Get Paid with Recurring Payments |
|
Main Subject - Nonprofit Fundraising - Get Paid with Recurring Payments
Benevolence, good will and philanthropy are honorable principles to adhere to and run by, but when bills start amassing, a nonprofit or charitable organization will not be excused from payment despite its inherent noble ideals and objectives. To make certain that all expenses will be pa According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product id - to ensure that its programs and services will remain in operation indefinitely - any nonprofit and/or charitable group must raise revenues on a consistent basis. Indeed, fundraising is so important that organizations often contract with professional fundraising firms to best determ ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ne how to continuously fill their coffers. In Post-September 11th America, the task of obtaining financial support has grown increasingly more difficult. As our economy remains in flux - as so many of our citizens continue to experience personal money woes - the act of providing larges lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e itself becomes jeopardized. Moreover, when tragedy strikes (e.g., act of terrorism on 9/11, Hurricane Katrina, etc.), so much of the charity shifts to "ground zero organizations" or others providing direct relief; other nonprofits and charities are affected and receive less support. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe esources have never been equitably distributed, and it behooves any agency to set itself apart as perhaps the "most worthy" - at least the charity of choice in a donor's mind. (It is a sad reality that organizations relying on public donations do compete with one another for scarce reso d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro rces.) Consequently, nonprofit and charitable organizations need to be business-savvy to maximize funds. Marketing must be pursued to increase income as prospective donors may learn of the group through a variety of sources: media, telemarketing, special events, and direct mail may be ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc oordinated and utilized to "spread the word." From these efforts, people pledge and give financial assistance, building a donor base. However, it is interesting to note that most donors give a one-time payment and that usually represents a lifetime contribution. Some organizations do n easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t even call donors back at a later juncture to ask for more money, eliminating good prospects and additional revenue. Indeed, it is imperative for an organization to establish regular dialogue with former donors. However, what is not apparent and regularly practiced is to design a pledg nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically program where individuals may contribute on a consistent basis (e.g., every month). Regular donations may be received with a preauthorized payment as individuals authorize the organization to deduct money from their bank accounts at certain time intervals. For example, an individual c and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ n specify that he/she wants to give $100 every month, to be deducted automatically. The funds will be transferred from the donor's account to the organization's account, typically via an electronic fund transfer. In the aforementioned example, the organization will have collected $1,200 ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi at the end of the year. The monthly pledge program (the time frame can be altered) offers a multitude of advantages. The following list gives eight great reasons why a nonprofit and/or charity should implement it as soon as possible: 1. Explosive income potential - Simply ask and you ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a may receive. Donors may very well contribute if a direct request is made. Instead of only receiving a one-time payment, an organization may, for example, receive 12 payments per year. Moreover, donors are likely to give more if their total donation can be subdivided over the course of t dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e year. 2. Convenience - New donors are attracted by the ease of making donations. They do not have to sign and forward a check but just merely provide authorization for automatic deductions. 3. Better rapport - The connection between the organization and donor grows closer over time. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Donors feel that they have an even more "personal stake" in the organization's welfare, and are more apt to volunteer time to participate in special events and other fundraising activities. 4. Increases retention rate - Donors are more likely to stay with the program. Long-term value s tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen udies reveal that those on preauthorized payments will be contributing to the organization long-term, many until their death. One person contributing $100/month for twenty years can result in $24,000 for the nonprofit and/or charitable group! 5. Reliable source of revenue - The organiz t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel tion is guaranteed income every month, which can cover a variety of monthly expenses (e.g., electric bills, telephone costs, etc.). The agency can budget its cash flow accordingly. 6. Savings - Administrative costs are dramatically reduced as there is much less paperwork. One person in ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust the agency can easily oversee and manage a recurring payment plan. 7. Claiming Share of Resources - An organization that wishes to stake its claim to limited resources and financial reserves must make certain that individuals join its preauthorized payments plan, rather than one for a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ompetitor. If donors participate in another agency's recurring payment plan, they may not be willing or able to join your program's plan. 8. Simplicity - It is very easy to establish a preauthorized plan arrangement. A donor fills out a simple form stipulating that he/she authorizes a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ransfer of money to an organization on a monthly basis. An electronic fund transfer then takes place with the assistance of a payment processing company. In light of the numerous advantages of a recurring payment plan, the operative question does not center on whether a nonprofit or ch elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip rity should adopt it, but "Why have they not done so thus far?" Any organization that is in the business of fundraising (which applies to all nonprofit and charitable groups) must avail itself to preauthorized payments and pledge to do so with expedience! Copyright 2006 William Hamilto tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Small Ads Produce Dynamic Results 4 Steps to Exploding Your Market With Small Ads Thoughts On Corporate Identity Career: Are You In The Right Seat
|